Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 423

1.

Inhaled nitric oxide in primary pulmonary hypertension: a safe and effective agent for predicting response to nifedipine.

Ricciardi MJ, Knight BP, Martinez FJ, Rubenfire M.

J Am Coll Cardiol. 1998 Oct;32(4):1068-73.

PMID:
9768734
[PubMed - indexed for MEDLINE]
Free Article
2.

Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension.

Sitbon O, Humbert M, Jagot JL, Taravella O, Fartoukh M, Parent F, Herve P, Simonneau G.

Eur Respir J. 1998 Aug;12(2):265-70.

PMID:
9727772
[PubMed - indexed for MEDLINE]
Free Article
3.

Echocardiographic predictors of an adverse response to a nifedipine trial in primary pulmonary hypertension: diminished left ventricular size and leftward ventricular septal bowing.

Ricciardi MJ, Bossone E, Bach DS, Armstrong WF, Rubenfire M.

Chest. 1999 Nov;116(5):1218-23.

PMID:
10559078
[PubMed - indexed for MEDLINE]
4.

Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension.

Leuchte HH, Schwaiblmair M, Baumgartner RA, Neurohr CF, Kolbe T, Behr J.

Chest. 2004 Feb;125(2):580-6.

PMID:
14769741
[PubMed - indexed for MEDLINE]
5.

Inhaled nitric oxide selectively dilates pulmonary vasculature in adult patients with pulmonary hypertension, irrespective of etiology.

Krasuski RA, Warner JJ, Wang A, Harrison JK, Tapson VF, Bashore TM.

J Am Coll Cardiol. 2000 Dec;36(7):2204-11.

PMID:
11127462
[PubMed - indexed for MEDLINE]
Free Article
6.
7.

A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group.

Hoeper MM, Olschewski H, Ghofrani HA, Wilkens H, Winkler J, Borst MM, Niedermeyer J, Fabel H, Seeger W.

J Am Coll Cardiol. 2000 Jan;35(1):176-82.

PMID:
10636277
[PubMed - indexed for MEDLINE]
Free Article
8.

Acute hemodynamic responses to inhaled nitric oxide in patients with limited scleroderma and isolated pulmonary hypertension.

Williamson DJ, Hayward C, Rogers P, Wallman LL, Sturgess AD, Penny R, Macdonald PS.

Circulation. 1996 Aug 1;94(3):477-82.

PMID:
8759092
[PubMed - indexed for MEDLINE]
Free Article
9.

Pulmonary hemodynamic responses to brain natriuretic peptide and sildenafil in patients with pulmonary arterial hypertension.

Klinger JR, Thaker S, Houtchens J, Preston IR, Hill NS, Farber HW.

Chest. 2006 Feb;129(2):417-25.

PMID:
16478861
[PubMed - indexed for MEDLINE]
10.

Effects of adenosine in combination with calcium channel blockers in patients with primary pulmonary hypertension.

Inbar S, Schrader BJ, Kaufmann E, Vestal RE, Rich S.

J Am Coll Cardiol. 1993 Feb;21(2):413-8.

PMID:
8426006
[PubMed - indexed for MEDLINE]
Free Article
11.

Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide.

Michelakis E, Tymchak W, Lien D, Webster L, Hashimoto K, Archer S.

Circulation. 2002 May 21;105(20):2398-403.

PMID:
12021227
[PubMed - indexed for MEDLINE]
Free Article
12.

Hemodynamic effects of inhaled nitric oxide in heart failure.

Semigran MJ, Cockrill BA, Kacmarek R, Thompson BT, Zapol WM, Dec GW, Fifer MA.

J Am Coll Cardiol. 1994 Oct;24(4):982-8.

PMID:
7930234
[PubMed - indexed for MEDLINE]
Free Article
13.

Comparison of the effects of nitric oxide, nitroprusside, and nifedipine on hemodynamics and right ventricular contractility in patients with chronic pulmonary hypertension.

Cockrill BA, Kacmarek RM, Fifer MA, Bigatello LM, Ginns LC, Zapol WM, Semigran MJ.

Chest. 2001 Jan;119(1):128-36.

PMID:
11157594
[PubMed - indexed for MEDLINE]
14.

Vasoresponsiveness of sarcoidosis-associated pulmonary hypertension.

Preston IR, Klinger JR, Landzberg MJ, Houtchens J, Nelson D, Hill NS.

Chest. 2001 Sep;120(3):866-72.

PMID:
11555522
[PubMed - indexed for MEDLINE]
15.

Hemodynamic effects of inhaled aerosolized iloprost and inhaled nitric oxide in heart transplant candidates with elevated pulmonary vascular resistance.

Sablotzki A, Hentschel T, Gruenig E, Schubert S, Friedrich I, Mühling J, Dehne MG, Czeslick E.

Eur J Cardiothorac Surg. 2002 Nov;22(5):746-52.

PMID:
12414041
[PubMed - indexed for MEDLINE]
16.

Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension.

Argenziano M, Choudhri AF, Moazami N, Rose EA, Smith CR, Levin HR, Smerling AJ, Oz MC.

Ann Thorac Surg. 1998 Feb;65(2):340-5.

PMID:
9485226
[PubMed - indexed for MEDLINE]
17.

Combined effects of nitric oxide and oxygen during acute pulmonary vasodilator testing.

Atz AM, Adatia I, Lock JE, Wessel DL.

J Am Coll Cardiol. 1999 Mar;33(3):813-9.

PMID:
10080486
[PubMed - indexed for MEDLINE]
Free Article
18.

Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.

Haraldsson A, Kieler-Jensen N, Nathorst-Westfelt U, Bergh CH, Ricksten SE.

Chest. 1998 Sep;114(3):780-6.

PMID:
9743166
[PubMed - indexed for MEDLINE]
19.

Adverse hemodynamic and clinical effects of calcium channel blockade in pulmonary hypertension secondary to obliterative pulmonary vascular disease.

Packer M, Medina N, Yushak M.

J Am Coll Cardiol. 1984 Nov;4(5):890-901.

PMID:
6491082
[PubMed - indexed for MEDLINE]
20.

Low doses of inhaled nitric oxide in heart transplant recipients.

Auler Júnior JO, Carmona MJ, Bocchi EA, Bacal F, Fiorelli AI, Stolf NA, Jatene AD.

J Heart Lung Transplant. 1996 May;15(5):443-50.

PMID:
8771498
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk